ENTITY
SMARTSCORE: 2.6/5

MorphoSys AG (MOR GR)

15
Analysis
Health CareGermany
MorphoSys AG operates as a biopharmaceutical company. The Company discovers and develops differentiated therapies and medicines for the patients suffering from cancer, inflammations, and autoimmune diseases. MorphoSys serves customers in Germany.
more
News Icon
No news found
We’ll display news we find for MorphoSys AG here
x